Physiological Effects of Non-invasive Mechanical Ventilation Versus High-flow Nasal Cannula in Critically Ill Patients At High Risk of Extubation Failure

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

April 24, 2024

Study Completion Date

April 24, 2024

Conditions
Weaning from Mechanical Ventilation
Interventions
DEVICE

Non-invasive ventilation (NIV)

Non-invasive ventilation will be provided through a mechanical ventilator (Carina, Dräger) through a facial interface (Fitlife Respironics, Philips). A PEEP level between 5 and 10 cmH2O, minimal pressure-support level of 5 cm H2O targeting a tidal volume around 6 to 8 ml/kg and at the same FiO2 applied during the spontaneous breathing trial.

DEVICE

High-flow nasal cannula

High flow nasal cannula will be provided through a commercial device (AIRVO2 + Optiflow nasal cannula, Fisher \& Paykel), at 50 LPM and at the same FiO2 applied during the spontaneous breathing trial.

Trial Locations (1)

114D

Hospital Clínico UC Christus, Santiago

All Listed Sponsors
collaborator

Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

OTHER_GOV

lead

Pontificia Universidad Catolica de Chile

OTHER

NCT05012696 - Physiological Effects of Non-invasive Mechanical Ventilation Versus High-flow Nasal Cannula in Critically Ill Patients At High Risk of Extubation Failure | Biotech Hunter | Biotech Hunter